ExploreIterate

Julie Louise Gerberding

CEO

Dr. Gerberding joined the FNIH as CEO on May 16, 2022. She served before that as chief Patient Officer and Executive Vice President, Population Health & Sustainability, at Merck & Co., Inc. She was responsible for patient engagement, corporate social responsibility, Environmental/Social/Governance issues, and other functions. Formerly, Dr. Gerbe...

Roles at Foundation for the National Institutes of Health

  • CEO

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Foundation for the National Institutes of Health

My pet peeves

My communication style

Org chart

Manager

No manager

Direct reports

Donald Hill

Chief Financial Officer

David Wholley

EVP, Strategy & Business Development

Robert Balthaser

VP, Advancement

View all

View in org chart
Teams

No teams

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.